Back to TUDOR INVESTMENT CORP ET AL TUDOR INVESTMENT CORP ET AL

TVTXTVTX
Showing 8 of 21 quarters

Position history for TUDOR INVESTMENT CORP ET ALTUDOR INVESTMENT CORP ET AL's holdings in TRAVERE THERAPEUTICS INC

TUDOR INVESTMENT CORP ET AL holds 5,955 shares of TVTX (TRAVERE THERAPEUTICS INC), worth $338,304 as of 2026-Q2. The position was decreased (-82.2% shares). TVTX represents 0.0% of TUDOR INVESTMENT CORP ET AL's portfolio.

Current Value

$338,304

Current Shares

5,955

Total Value Change

-$195,331

Total Shares Change

-32,189

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
5,955
-82.2%
$338,3040.0%$56.81
0
2026-Q1
Decreased
33,361
-46.4%
$991,1550.0%$28.27
0
2025-Q4
Decreased
62,186
-35.0%
$2.4M0.0%$37.68
0
2025-Q3
Decreased
95,747
-52.5%
$2.3M0.0%$24.04
0
2025-Q2
Increased
201,508
+23.3%
$3M0.0%$14.77
32
2025-Q1
Increased
163,378
+278.1%
$2.9M0.0%$19.68
42
2024-Q4
Increased
43,213
+13.3%
$752,7700.0%$17.32
28
2024-Q3
Increased
38,144
+2.3%
$533,6350.0%$14.01
25

Other major holders of TVTX: BlackRock, Inc., FMR LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used